AM
Amgen
AMGN · NASDAQ
$437.23 +0.05% (+$0.20)
1M +4.80%
Market Cap $236.0B
P/E Ratio 26.99x
Div. Yield 2.24%
ROE 89.32%
Bulios Fair Price
$441.6
1.0% upside
Trenutna cena
$437.23
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica AMGN trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
44 /100
Fair P/E 26.99x
EV/EBITDA 16.92x
P/S 6.19x
Growth
53 /100
Stable EPS growth 5.52%
Rev. growth 11.76%
FCF growth 2.67%
Profitability
100 /100
Strong Gross margin 72.65%
Net margin 22.93%
Op. margin 33.18%
Quality
78 /100
Excellent ROIC 14.22%
ROE 89.32%
ROA 9.14%
Debt
37 /100
Moderate Debt/Equity 4.90x
Current ratio 1.37x
Int. coverage 4.86x
Stability
64 /100
Moderate Beta 0.41x
Rev. volatility 5.98%
EPS volatility 65.02%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AMGN
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert A. Bradway
Employees
31,500
Headquarters
Thousand Oaks
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report